A forward-looking McMaster donor is investing $7 million in a new research centre dedicated specifically to tackling the growing global threat of antimicrobial resistance.
There already exist some promising new antibiotic therapies, and more are in the pipeline -- but our economic model prevents researchers from moving them out onto the market.
McMaster’s Michael G. DeGroote Institute for Infectious Disease Research joins the World Health Organization in promoting safe antibiotic use.
McMaster logo
McMaster logo
